UN to vote on cloning in a year

Last-minute change to cut delay in talks from 2 years to 1 year angers UK

Written byTheresa Tamkins
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

UNITED NATIONS, NY—The United Nations will reopen talks on a human cloning ban next year rather than in 2 years, a decision marked by the back-and-forth wrangling that has become de rigeur among countries unable to reach a consensus on the issue.

Indeed, the last-minute maneuvering by a US-led coalition of nations to reverse an earlier vote by the UN's Sixth Committee, which opted for the 2-year wait, appeared to infuriate the United Kingdom.

“The United Kingdom is profoundly disappointed by the actions of those who sought until very recently to overturn the decision of the Sixth Committee. During the deliberations of the Sixth Committee, we made clear the views of the United Kingdom. The UK is totally opposed to reproductive cloning, and we were one of the first countries in the world to introduce specific legislation to ban this possibility. However, in our view, therapeutic cloning is a different ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies